- Home
- ARMP vs RELL Comparison
ARMP vs RELL Comparison
Compare ARMP & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | RELL |
|---|---|---|
| Founded | N/A | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.7M | 149.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARMP | RELL |
|---|---|---|
| Price | $5.76 | $10.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 69.4K | 52.9K |
| Earning Date | 11-12-2025 | 01-06-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $5,054,000.00 | ★ $209,791,000.00 |
| Revenue This Year | $4.48 | $4.72 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | ★ N/A | $903.34 |
| Revenue Growth | N/A | ★ 6.17 |
| 52 Week Low | $0.90 | $7.57 |
| 52 Week High | $16.34 | $15.51 |
Technical Indicators
Market Signals| Indicator | ARMP | RELL |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 55.58 |
| Support Level | $5.67 | $10.72 |
| Resistance Level | $6.39 | $11.47 |
| Average True Range (ATR) | 0.58 | 0.40 |
| MACD | -0.13 | 0.06 |
| Stochastic Oscillator | 22.38 | 59.56 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.